RHX-317

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameRHX-317
Drug Alias NameRHX-317
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMucosa-associated lymphoid tissue lymphoma translocation protein 1 inhibitors
TargetsMucosa-associated lymphoid tissue lymphoma translocation protein 1
Therapy Area/IndicationsGraft vs Host DiseaseLupus Nephritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsGraft vs Host DiseaseLupus Nephritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A